欧洲体外诊断市场预测至 2030 年 – 区域分析 – 按产品和服务（试剂和试剂盒、仪器以及软件和服务）、技术（免疫测定/免疫化学、临床化学、分子诊断、微生物学、血糖）自我监测、凝血和止血、血液学、尿液分析等）、应用（传染病、糖尿病、肿瘤学、心脏病学、自身免疫性疾病、肾病学等）和最终用户（医院、实验室、家庭护理等）
No. of Pages: 124 | Report Code: TIPRE00022122 | Category: Life Sciences
No. of Pages: 124 | Report Code: TIPRE00022122 | Category: Life Sciences
用于体外诊断的 IVD传染病的诊断包括免疫测定和分子测定。诊断公司还致力于快速改进其管理 COVID-19 的产品。此外，监管机构对其标准进行了临时修订或修改，这有利于在大流行期间推出新的体外诊断设备。由于这些政府举措，对分子诊断和免疫测定的需求激增。此外，许多公司扩大了 IVD 制造的产品线。
2021 年 6 月，英国体外诊断协会 (BIVDA) 启动了“数字革命”计划。鼓励在 COVID-19 大流行期间体外诊断取得突破的战略。 2022 年 7 月，BioGX 宣布在其 Pixel 平台上推出带有 CE 标志的三基因即时护理 (POC) 多重 COVID-19 测试。因此，由于对即时 (POC) 诊断和实验室检测程序的需求不断增长，COVID-19 大流行使体外诊断市场受益。
欧洲体外诊断市场已细分为德国、法国、英国、意大利、西班牙和欧洲其他地区。该地区的市场增长归因于疾病诊断意识的提高、人口老龄化的加剧以及体外诊断技术的进步，从而主导了整体市场的增长。德国占据欧洲体外诊断（IVD）市场的最大份额。德国IVD行业以其创新能力而闻名。其 IVD 行业受益于分子生物学、小型化和自动化的发展。德国“工业 4.0”项目正在进行数字化，特别是在 ICD 领域，“实验室 4.0”专为数据处理、基于云的 IT 解决方案、实验室和生产自动化流程以及数字网络而开发。
IVD在 COVID-19 大流行期间，德国市场的需求大幅增长。全面检测是德国政府抗击疫情和保护民众免受感染的卫生政策战略的核心组成部分。总部位于德国的公司在开发分子测试以及用于分子信息生物分析的高科技仪器和耗材方面是公认的创新者。拥有实验室自动化系统的公司通过推出创新产品来推动体外诊断的发展，推动了德国体外诊断市场的发展。
欧洲体外诊断市场分为产品和市场。服务、技术、应用程序、最终用户和国家/地区。
基于产品和国家/地区。服务，欧洲体外诊断市场分为试剂和服务。套件、仪器、软件和服务。试剂&到2022年，试剂盒细分市场将占据欧洲体外诊断市场的最大份额。
根据技术，欧洲体外诊断市场细分为免疫测定/免疫化学、临床化学、分子诊断、微生物学、血糖自我监测、凝血及血糖监测止血、血液学、尿液分析等。到2022年，免疫测定/免疫化学领域在欧洲体外诊断市场中占据最大份额。
根据应用，欧洲体外诊断市场分为传染病、糖尿病、肿瘤学、心脏病学、自身免疫性疾病、肾脏病学等。 2022年，传染病细分市场在欧洲体外诊断市场中占据最大份额。
根据最终用户，欧洲体外诊断市场分为医院、实验室、家庭护理等。 2022年，医院细分市场在欧洲体外诊断市场中占据最大份额。
按国家/地区划分，欧洲体外诊断市场分为德国、法国、英国、意大利、西班牙和欧洲其他地区。 2022 年，欧洲其他地区将主导欧洲体外诊断市场。
雅培 (Abbott Laboratories)、贝克顿·迪金森 (Becton Dickinson) 有限公司、生物梅里埃 (bioMerieux SA)、伯乐 (Bio-Rad) Laboratories Inc、丹纳赫公司 (Danaher Corp)、F. Hoffmann-La Roche Ltd、 Qiagen NV、Siemens AG、Sysmex Corp 和 Thermo Fisher Scientific Inc 是欧洲体外诊断市场上的一些领先公司。
Strategic insights for Europe In-Vitro Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 22,616.55 Million |
| Market Size by 2030 | US$ 34,247.12 Million |
| Global CAGR (2022 - 2030) | 5.3% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By 产品与服务
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe In-Vitro Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe In-Vitro Diagnostics Market is valued at US$ 22,616.55 Million in 2022, it is projected to reach US$ 34,247.12 Million by 2030.
As per our report Europe In-Vitro Diagnostics Market, the market size is valued at US$ 22,616.55 Million in 2022, projecting it to reach US$ 34,247.12 Million by 2030. This translates to a CAGR of approximately 5.3% during the forecast period.
The Europe In-Vitro Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe In-Vitro Diagnostics Market report:
The Europe In-Vitro Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe In-Vitro Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe In-Vitro Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe In-Vitro Diagnostics Market
